USPTO serial 79269627
PROYILTIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 16, 2021
- Examiner
- STADELI, MARTA ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PROYILTIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
Mary Margaret L. O'Donnell Blue Filament Law PLLC700 E. Maple RoadSuite 450Birmingham, MI 48009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietary supplements, namely, tablets for medical use; dietetic preparations in tablet form, namely, dietetic sugar substitutes for medical use and dietetic beverages adapted for medical use; diagnostic preparations for medical purpose; medical dressings and plasters for application on the skin; pharmaceutical natural remedies for the treatment of nephrological, hematological or neurological diseases; activated charcoal for adsorption of toxins for medical purposes; medical adhesives for affixing prostheses; alcohol for pharmaceutical purposes; amino acid preparations for medical purposes; amino acid preparations for veterinary use; insecticides, namely, flea dip preparations; animal semen for artificial insemination; animal sperm; antibiotics for fish; antibiotic food supplements for animals; antipyretic preparations; attractants for pet animals, namely, pet training aids in the form of drops to toilet train animals; arsenic detoxification agents for medical purposes; bacterial poisons; bacterial preparations for medical and veterinary use; bacterial preparations for medical purposes; bacterial preparations for veterinary purposes; bacteriological preparations for medical purposes; bacteriological preparations for veterinary purposes; bark extract for medical use; bark extract for veterinary use; by-products of the processing of cereals for medical purposes; medicated chewing gum for treating nephrological, hematological or neurological diseases; breath refreshers for medical purposes in the nature of medicated mouth wash used in treating breath malodor; bone growth media consisting of biological materials for medical purposes; bone cements for surgical purposes; bone cements for orthopaedic purposes; bone cement for surgical and orthopaedic purposes; bone cement for medical purposes; blood substitutes for medical purposes; blood protein fractions for medical diagnostic and therapeutic purposes; blood plasma; blood for medical purposes; blood components in the nature of platelet rich blood plasma and stem cells for medical uses; biological tissue cultures for veterinary purposes; biological tissue cultures for medical purposes; veterinary biological preparations for the treatment of nephrological, hematological or neurological diseases; medical biological preparations for the treatment of nephrological, hematological or neurological diseases; biological indicators for monitoring sterilization processes for medical or veterinary purposes; veterinary biochemical preparations for the treatment of nephrological, hematological or neurological diseases; medical biochemical preparations for the treatment of nephrological, hematological or neurological diseases; benzol detoxification agents for medical purposes; bath salts for medical purposes; bath preparations for medical purposes; nutritional supplements, namely, bark powder for veterinary use; nutritional supplements, namely, bark powder for medical use; cord blood for medical use; cooling sprays for medical purposes; contraceptive sponges; contraceptive foams; collodion for pharmaceutical purposes; collagen for medical purposes; chromatographic supports for medical use, namely, drug delivery agents in the form of a coating for gastro resistant tablets that facilitate the delivery of a wide range of pharmaceuticals; chlorine detoxification agents for medical purposes; chemical reagents for veterinary purposes; chemical reagents for medical purposes; chemical contraceptives; chemical contraceptive sponges; cement for animal hooves; cellulose ethers for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; cellular function activating agents for medical purposes; caustic pencils; cardiovascular agents for medical purposes; capsules sold empty for pharmaceuticals; capsules sold empty for medicines; cantharides preparations for medical use; cantharides preparations for veterinary use; cachets being medicine capsules sold empty for pharmaceutical purposes; cachets being medicine capsules sold empty for medicinal purposes; gases and gas mixtures for medical imaging use; gas mixtures for medical use; first-aid boxes, filled; dietary supplements, namely, fodder additives for animals; first aid kits for domestic use; feeding stimulants for animals; feed supplements for veterinary use; eye drops; enzymes for veterinary purposes; enzymes for medical purposes; enzyme preparations for veterinary purposes; enzyme preparations for medical purposes; enema preparations; ear candles for therapeutic purposes; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; douching preparations for medical purposes; medicated dog skin lotions for veterinary purposes; diagnostic radiopharmaceutical preparations; dextrins for pharmaceutical use; medicated bath crystals for therapeutic purposes; corn remedies, namely, corn pads and plasters; cord blood for medical purposes; medical adhesives for binding wounds; medical adhesives for binding internal tissue; materials for surgical casts in the nature of surgical plasters; marine antifoulants in the nature of pesticides; liquid bandage sprays; leeches for medical purposes; isotopes for medical purposes; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; injectable dermal filler; medicated wipes impregnated with antibacterial preparations; hydrogen peroxide for medical purposes; herbal sore skin ointments for pets; herbal anti-itch ointments for pets; haemostatic pencils; haemoglobin; greases for veterinary purposes; greases for medical purposes; greases for medical or veterinary purposes; gravel as a digestive aid for birds; gelatine for medical purposes; gases for medical purposes; mixed biological preparations for the treatment of nephrological, hematological or neurological diseases for medical purposes; mineral waters for medical purposes; mineral water salts for medical purposes; mineral preparations for medical purposes; mineral food supplement preparations for medical purposes; milking grease for veterinary purposes; milk sugar being lactose for medical purposes; microbicides; methionine preparations; menthol vapor bath preparations for babies; medicines for the treatment of nephrological, hematological or neurological diseases for veterinary purposes; medicinal mud; medicinal clay preparations; medicinal healthcare preparations for the treatment of nephrological, hematological or neurological diseases; medicinal alcohol; medicated toiletry preparations; medicated shampoos for pets; medicated massage candles for therapeutic purposes; medicated eye-washes; medicated shampoos; medicated dry shampoos; medicated baby oils; medicated after-shave lotions; medicated additives for animal foods for use as a nutritional supplement; radio-isotope markers for therapeutic or diagnostic use; radiation sickness treating agents; preparations of trace elements for human and animal use in the nature of nutritional supplements; preparations for use in naturopathy, namely, natural sleep aid preparations; portable first-aid kits; pheromones for medical use; veterinary pharmaceutical preparations for the treatment of nephrological, hematological or neurological diseases; pharmaceutical preparations for animals for the treatment of nephrological, hematological or neurological diseases; petroleum jelly for medical or veterinary purposes; pearl powder for medical purposes; paracetamol preparations for oral administration; paracetamol preparations for intravenous administration; paracetamol modified release preparations; pain relief medication for veterinary purposes; panthenol preparations for medical use, namely, for the treatment of nephrological, hematological or neurological diseases; oxygen bath preparations for medicinal use; organotherapeutics; oral vaccine preparations; oral rehydration salts; oiled paper for medical purposes; nutritional supplements for veterinary use; nucleic acid sequences for medical and veterinary purposes; medicinal mud for baths; surgical bone cements; stem cells for veterinary purposes; stem cells for medical purposes; solvents for removing adhesive plasters; solidified gases for medical purposes; solid oxygen for medical use; semen for artificial insemination; sealed radioactive substances for medical use; sea water for medicinal bathing; medicated skin scrubs for medical use; sanitary preparations for veterinary use; sandalwood oil for medical, pharmaceutical and veterinary purposes; rubbing alcohol; repellents for dogs; salts for mineral water baths for medical purposes; reconstituted cells for medical skin care treatments; reconstituted cells for clinical skin care treatments; reagents for use in veterinary genetic testing; reagents for use in medical genetic testing; reagents for medical use; radium for medical purposes; radiotherapeutic hormones; radioactive substances for medical purposes; radioactive elements for medical use; yeast for medical, veterinary or pharmaceutical purposes; yeast extracts for medical, veterinary or pharmaceutical purposes; vitamin and mineral preparations for medical purposes; veterinary preparations and substances for the treatment of nephrological, hematological or neurological diseases; veterinary biological, biochemical, medicines and pharmaceutical preparations for the treatment of nephrological, hematological or neurological diseases; vascular grafts being living tissue; vaccines; vaccines for human use; urease for medical purposes; medicated udder creams for agricultural use; tryptophane preparations; trypsins for medical purposes; trichomycin preparations; trace element preparations for use by animals, namely, dietary and nutritional supplements; trace element preparations for human use, namely, dietary and nutritional supplements; tobacco-free cigarettes for smoking cessation purposes; thermal water being mineral water for medical purposes; therapeutic medicated preparations for the bath; medicated teat dips for dairy cows; surgical glues | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 16, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 11, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 17, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 17, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 16, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 16, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 10, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 29, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 29, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 23, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 23, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 9, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 19, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 19, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 19, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 18, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 26, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 26, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 26, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 7, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 7, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 7, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 23, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 29, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 29, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 7, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 6, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 18, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 17, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |